Avadel Pharmaceuticals Stock (NASDAQ:AVDL)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$15.47

52W Range

$10.17 - $19.09

50D Avg

$13.74

200D Avg

$15.25

Market Cap

$1.45B

Avg Vol (3M)

$932.63K

Beta

1.63

Div Yield

-

AVDL Company Profile


Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

Yes

Country

IE

Employees

154

IPO Date

Jun 07, 1996

Website

AVDL Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 20
Vazculep$10.43M
Other Products$159.00K
Bloxiverz$2.20M
License-
Akovaz$9.54M

Fiscal year ends in Dec 23 | Currency in USD

AVDL Financial Summary


Dec 23Dec 22Dec 21
Revenue$27.96M--
Operating Income$-137.85M$-98.56M$-85.55M
Net Income$-160.28M$-137.46M$-77.33M
EBITDA$-136.08M$-93.72M$-84.57M
Basic EPS$-2.00$-2.29$-1.32
Diluted EPS$-2.00$-2.29$-1.32

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q2 24Aug 09, 24 | 12:27 PM
Q1 24May 08, 24 | 12:00 AM
Q4 23Mar 04, 24 | 10:43 AM

Peer Comparison


TickerCompany
ITCIIntra-Cellular Therapies, Inc.
EVOKEvoke Pharma, Inc.
ANIPANI Pharmaceuticals, Inc.
AMRXAmneal Pharmaceuticals, Inc.
AQSTAquestive Therapeutics, Inc.
LFCRLifecore Biomedical, Inc.
DVAXDynavax Technologies Corporation
NBIXNeurocrine Biosciences, Inc.
IRWDIronwood Pharmaceuticals, Inc.
ASRTAssertio Holdings, Inc.
DERMJourney Medical Corporation
ACRXTalphera, Inc.
DCPHDeciphera Pharmaceuticals, Inc.
JUPWSafety Shot Inc
AGRXAgile Therapeutics, Inc.
ALKSAlkermes plc
EGRXEagle Pharmaceuticals, Inc.